Andrew Dagis

2.1k total citations
38 papers, 1.4k citations indexed

About

Andrew Dagis is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Andrew Dagis has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 12 papers in Oncology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Andrew Dagis's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Lymphoblastic Leukemia research (10 papers) and Acute Myeloid Leukemia Research (8 papers). Andrew Dagis is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Lymphoblastic Leukemia research (10 papers) and Acute Myeloid Leukemia Research (8 papers). Andrew Dagis collaborates with scholars based in United States, Canada and Slovakia. Andrew Dagis's co-authors include Stephen J. Forman, Anthony S. Stein, Joyce C. Niland, David S. Snyder, G. Schmidt, Vinod Pullarkat, James Andersen, Lawrence D. Wagman, Joshua D.I. Ellenhorn and David Z. J. Chu and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Andrew Dagis

37 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Dagis United States 20 897 363 329 267 207 38 1.4k
Isabel Badell Spain 24 806 0.9× 265 0.7× 311 0.9× 328 1.2× 279 1.3× 108 1.6k
Hisato Kigasawa Japan 21 988 1.1× 197 0.5× 392 1.2× 366 1.4× 182 0.9× 60 1.5k
Richard Champlin United States 19 1.1k 1.2× 251 0.7× 638 1.9× 428 1.6× 191 0.9× 52 1.7k
N Philippe France 18 456 0.5× 327 0.9× 220 0.7× 234 0.9× 266 1.3× 59 1.4k
Ronit Yerushalmi Israel 24 1.0k 1.2× 407 1.1× 772 2.3× 435 1.6× 273 1.3× 105 1.9k
Esteban Abella United States 17 551 0.6× 233 0.6× 512 1.6× 202 0.8× 155 0.7× 56 1.3k
Irena Sniecinski United States 22 1.1k 1.2× 375 1.0× 510 1.6× 212 0.8× 281 1.4× 49 1.8k
Boglarka Gyurkocza United States 17 1.3k 1.5× 252 0.7× 377 1.1× 511 1.9× 244 1.2× 68 1.7k
Jeffrey Margolis United States 18 524 0.6× 278 0.8× 307 0.9× 103 0.4× 154 0.7× 35 1.1k
Silvia Park South Korea 21 650 0.7× 218 0.6× 581 1.8× 165 0.6× 203 1.0× 163 1.5k

Countries citing papers authored by Andrew Dagis

Since Specialization
Citations

This map shows the geographic impact of Andrew Dagis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Dagis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Dagis more than expected).

Fields of papers citing papers by Andrew Dagis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Dagis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Dagis. The network helps show where Andrew Dagis may publish in the future.

Co-authorship network of co-authors of Andrew Dagis

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Dagis. A scholar is included among the top collaborators of Andrew Dagis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Dagis. Andrew Dagis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pawłowska, Anna, George T. Calvert, Nicole Karras, et al.. (2020). Long-Term Follow-up of High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Children and Young Adults with Metastatic or Relapsed Ewing Sarcoma: A Single-Institution Experience. Transplantation and Cellular Therapy. 27(1). 72.e1–72.e7. 2 indexed citations
2.
He, Ting-Fang, Susan E. Yost, Paul Frankel, et al.. (2020). Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis. PLoS ONE. 15(3). e0229955–e0229955. 20 indexed citations
3.
Aldoss, Ibrahim, Andrew Dagis, Joycelynne Palmer, Stephen J. Forman, & Vinod Pullarkat. (2015). Therapy-related ALL: cytogenetic features and hematopoietic cell transplantation outcome. Bone Marrow Transplantation. 50(5). 746–748. 15 indexed citations
4.
Shayani, Sepideh, Joycelynne Palmer, Andrew Dagis, et al.. (2015). Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation. Supportive Care in Cancer. 23(11). 3141–3147. 13 indexed citations
5.
Chen, Bihong T., et al.. (2012). Brain imaging findings in symptomatic patients after allogeneic haematopoietic stem cell transplantation: correlation with clinical outcome. European Radiology. 22(10). 2273–2281. 8 indexed citations
6.
Gallez‐Hawkins, Ghislaine, Anne Franck, Xiuli Li, et al.. (2011). Expression of Activating KIR2DS2 and KIR2DS4 Genes after Hematopoietic Cell Transplantation: Relevance to Cytomegalovirus Infection. Biology of Blood and Marrow Transplantation. 17(11). 1662–1672. 33 indexed citations
7.
Kirschbaum, Mark, Anthony S. Stein, Leslie Popplewell, et al.. (2011). A Phase I Study in Adults of Clofarabine Combined with High-Dose Melphalan as Reduced-Intensity Conditioning for Allogeneic Transplantation. Biology of Blood and Marrow Transplantation. 18(3). 432–440. 19 indexed citations
8.
Stein, Anthony S., Margaret O’Donnell, Timothy W. Synold, et al.. (2010). Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia. Bone Marrow Transplantation. 46(9). 1256–1262. 3 indexed citations
9.
Pullarkat, Vinod, Marilyn L. Slovak, Andrew Dagis, et al.. (2009). Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation. Annals of Oncology. 20(12). 2000–2006. 11 indexed citations
10.
Zaia, John A., Joel Y. Sun, Ghislaine Gallez‐Hawkins, et al.. (2009). The Effect of Single and Combined Activating Killer Immunoglobulin-like Receptor Genotypes on Cytomegalovirus Infection and Immunity after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 15(3). 315–325. 72 indexed citations
11.
Krishnan, Amrita, Auayporn Nademanee, Henry C. Fung, et al.. (2006). Does Follicularity in Large Cell Lymphoma Predict Outcome after Autologous Stem Cell Transplantation?. Biology of Blood and Marrow Transplantation. 12(6). 641–647. 8 indexed citations
12.
Sun, Jiyao, Laima Gaidulis, Andrew Dagis, et al.. (2005). Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML. Bone Marrow Transplantation. 36(6). 525–530. 32 indexed citations
13.
Arber, Daniel A., David S. Snyder, Miriam Fine, et al.. (2001). Myeloperoxidase Immunoreactivity in Adult Acute Lymphoblastic Leukemia. American Journal of Clinical Pathology. 116(1). 25–33. 29 indexed citations
14.
15.
Peralta, Elizabeth A., Joshua D.I. Ellenhorn, Lawrence D. Wagman, et al.. (2000). Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. The American Journal of Surgery. 180(6). 439–445. 152 indexed citations
16.
17.
Nademanee, Auayporn, Arturo Molina, Henry C. Fung, et al.. (1999). High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission. Biology of Blood and Marrow Transplantation. 5(5). 292–298. 17 indexed citations
18.
19.
Schmidt, G., Joyce C. Niland, Stephen J. Forman, et al.. (1993). EXTENDED FOLLOW-UP IN 212 LONG-TERM ALLOGENEIC BONE MARROW TRANSPLANT SURVIVORS ISSUES OF QUALITY OF LIFE. Transplantation. 55(3). 551–556. 78 indexed citations
20.
Chao, Nelson J., G. Schmidt, Joyce C. Niland, et al.. (1993). Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease. New England Journal of Medicine. 329(17). 1225–1230. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabel Badell Breakdown of academic impact, for papers by Hisato Kigasawa Breakdown of academic impact, for papers by Richard Champlin Breakdown of academic impact, for papers by N Philippe Breakdown of academic impact, for papers by Ronit Yerushalmi Breakdown of academic impact, for papers by Esteban Abella Breakdown of academic impact, for papers by Irena Sniecinski Breakdown of academic impact, for papers by Boglarka Gyurkocza Breakdown of academic impact, for papers by Jeffrey Margolis Breakdown of academic impact, for papers by Silvia Park
Rankless by CCL
2026